Espace médias

PTCOG 2026 : CYCLHAD participera au congrès international de l’hadronthérapie à Deauville

CYCLHAD participera aux côtés des équipes du Centre François Baclesse à la 64ème édition du PTCOG 2026 (Particle Therapy Co-Operative Group), le congrès interna...

CYCLHAD ANNONCE LA CONSTITUTION DE SON CONSEIL SCIENTIFIQUE

CYCLHAD annonce la création de son Conseil Scientifique pour structurer l’hadronthérapie en France et accélérer l’innovation au service des patients atteints de...

Symposium international Hadrontherapy for Life (EN)

Discover the major advancements in hadron therapy and download the full report from the Hadrontherapy for Life symposium.

PROTON THERAPY : A PROMISING APPROACH FOR SKIN CANCERS

Explore the expanding role of particle therapy in managing primary and recurrent non-melanoma skin cancers (NMSC). In this exclusive webinar, leading experts fr...

MEDICO-ECONOMICS & NETWORKS IN HADRONTHERAPY

Particle therapy combines cutting-edge physics, biology, and clinical care to treat complex cancers. Beyond clinical outcomes, its economic, societal, and scien...

MEDICAL PHYSICS, INSTRUMENTATION & TECHNOLOGY IN HADRONTHERAPY

Hadrontherapy is at the forefront of precision oncology, combining advanced physics, engineering, and biology to treat cancer with unmatched accuracy. Innovatio...

RADIOBIOLOGY & CARCINOGENESIS OF PARTICLES

During the Hadrontherapy for Life symposium held in March 2025 in Caen, France, leading international experts outlined how particle therapy can overcome radiore...

Symposium international Hadrontherapy for Life (FR)

Découvrez les avancées majeures de la hadronthérapie et téléchargez le rapport complet du symposium Hadrontherapy for Life.

CLINICAL INDICATIONS IN CARBON-ION RADIOTHERAPY

During the Hadrontherapy for Life symposium held in March 2025 in Caen, France, leading international experts reviewed global carbon-ion and proton therapy prog...